Moomoo AI 已提取核心信息
Kathryn E Wengel, EVP, Chief TO and Risk Officer at Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. This information is essential for investors to understand the implications of the transaction on their investment decisions.
Kathryn E Wengel, EVP, Chief TO and Risk Officer at Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. This information is essential for investors to understand the implications of the transaction on their investment decisions.
强生公司执行副总裁、首席技术官兼风险官凯瑟琳·温格尔于2024年2月15日参与了该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。也没有提供交易的操作类型和状态。这些信息对于投资者了解交易对其投资决策的影响至关重要。
强生公司执行副总裁、首席技术官兼风险官凯瑟琳·温格尔于2024年2月15日参与了该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。也没有提供交易的操作类型和状态。这些信息对于投资者了解交易对其投资决策的影响至关重要。
有用
没用